(msc)

The debate on MSCs is over; it’s time to promote MSC therapy in practiceThe debate on MSCs is over; it’s time to promote MSC therapy in practice

The debate on MSCs is over; it’s time to promote MSC therapy in practice

TIANJIN, China, Feb. 26, 2025 /PRNewswire/ -- The debate on MSCs, mesenchymal stromal cells versus mesenchymal stem cells, continued for…

2 months ago
Mesoblasts RYONCIL is the First U.S. FDA-Approved Mesenchymal Stromal Cell (MSC) TherapyMesoblasts RYONCIL is the First U.S. FDA-Approved Mesenchymal Stromal Cell (MSC) Therapy

Mesoblasts RYONCIL is the First U.S. FDA-Approved Mesenchymal Stromal Cell (MSC) Therapy

December 18, 2024 19:08 ET  | Source: Mesoblast Limited RYONCIL (remestemcel-L) is the first MSC product approved by FDA for…

4 months ago